KRAS mutant bowel cancers segregate into two distinct subgroups

被引：0

作者：

Borowsky, J. ^{[1
,2
,3
]}

Su, C. ^{[1
]}

Fennell, L. ^{[1
]}

Burge, M. ^{[4
]}

Liu, J. ^{[2
]}

Costa, A. Dias ^{[8
]}

Ogino, S. ^{[9
,10
,11
]}

Mckeone, D. ^{[2
]}

Olsen, K. ^{[2
]}

Badshah, J. ^{[2
]}

Bond, C. ^{[2
]}

Nowlan, B. ^{[2
]}

Tria, S. ^{[2
]}

Laki, V. ^{[2
]}

Walker, N. ^{[6
]}

Brown, I. ^{[6
]}

Bettington, M. ^{[6
]}

Leggett, B. ^{[2
,5
]}

Whitehall, V. ^{[2
,7
]}

机构：

[1] Queensland Hlth, Pathol Queensland, Brisbane, Qld, Australia

[2] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia

[3] Univ Queensland, Sch Med, Brisbane, Australia

[4] Royal Brisbane & Womens Hosp, Dept Med Oncol, Herston, Qld, Australia

[5] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Herston, Qld, Australia

[6] Envoi Pathol, Brisbane, Australia

[7] Queensland Hlth, Conjoint Internal Med Lab, Pathol Queensland, Brisbane, Qld, Australia

[8] Dana Farber Canc Inst, Boston, MA USA

[9] Harvard Med Sch, Dept Pathol, Program MPE Mol Pathol Epidemiol, Brigham & Womens Hosp, Boston, MA USA

[10] Broad Inst MIT & Harvard, Cambridge, MA USA

[11] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

239

引用

页码：28 / 29

页数：2

共 50 条

[21] KRAS-Mutant Lung Cancers in the Era of Targeted Therapy
Naidoo, Jarushka
Drilon, Alexander
LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 : 155 - 178
[22] Analysis of KRAS and BRAF mutant colorectal cancers in a multiracial population
Acoba, Jared David
Lum, Christopher A.
Leong, Lambert T.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[23] c-Raf in KRas Mutant Cancers: A Moving Target
McCormick, Frank
CANCER CELL, 2018, 33 (02) : 158 - 159
[24] Nucleic Acid-Based Approaches to Tackle KRAS Mutant Cancers
Kim, Jimi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
[25] Recent advances in overcoming resistance to targeted therapy in KRAS mutant cancers
Adachi, Yuta
Niitsu, Hiroaki
Ebi, Hiromichi
CANCER SCIENCE, 2023, 114 : 986 - 986
[26] Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, Chunxiao
Guan, Xiaoqing
Zhang, Xinuo
Luan, Xin
Song, Zhengbo
Cheng, Xiangdong
Zhang, Weidong
Qin, Jiang-Jiang
MOLECULAR CANCER, 2022, 21 (01)
[27] Understanding the complex biology of KRAS mutant cancers using genetic screens
Tina, L.
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
[28] Gene Expression Profiles of Rectal Cancers with Mutant or Wild Type KRAS
Garcia-Aguilar, J.
Chen, Z.
Warden, C.
Avila, K.
Zhou, N.
Yuan, Y.
Chen, C.
Weiser, M. R.
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S14 - S14
[29] Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway
Korzeniecki, Claudia
Priefer, Ronny
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 211
[30] Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Chunxiao Zhu
Xiaoqing Guan
Xinuo Zhang
Xin Luan
Zhengbo Song
Xiangdong Cheng
Weidong Zhang
Jiang-Jiang Qin
Molecular Cancer, 21

← 1 2 3 4 5 →